Circulating metabolomics reveals guanosine monophosphate synthetase (<scp>GMPS</scp>) as a novel therapeutic target in lung adenocarcinoma
Jiye Aa(China Pharmaceutical University), Yang Dou(Chinese Academy of Sciences), Danxia Zhu(Soochow University), Yue Wang(Shandong University of Traditional Chinese Medicine), Wei Zhu(Ministry of Education of the People's Republic of China), Minmin Cao, Guangji Wang(China Pharmaceutical University), Jingfeng Zhu(Huadong Hospital)
Cited by 1
Related Papers
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
|Annals of the Rheumatic Diseases|2011|412
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
|PLoS ONE|2012|196
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
|Molecular Pharmacology|2016|196
A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patients
|Annals of the Rheumatic Diseases|2013|168
The Antihyperglycaemic Activity of Berberine Arises from a Decrease of Glucose Absorption
|Planta Medica|2003|137